ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 46 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,030,000 | +0.4% | 900,000 | 0.0% | 0.00% | – |
| Q3 2019 | $1,026,000 | -3.9% | 900,000 | 0.0% | 0.00% | – |
| Q2 2019 | $1,068,000 | -12.2% | 900,000 | 0.0% | 0.00% | – |
| Q1 2019 | $1,217,000 | +182.4% | 900,000 | +125.0% | 0.00% | – |
| Q4 2018 | $431,000 | -54.5% | 400,000 | -55.6% | 0.00% | – |
| Q3 2018 | $947,000 | +7.4% | 900,000 | 0.0% | 0.00% | – |
| Q2 2018 | $882,000 | -25.9% | 900,000 | -25.0% | 0.00% | – |
| Q1 2018 | $1,190,000 | -6.0% | 1,200,000 | 0.0% | 0.00% | – |
| Q4 2017 | $1,266,000 | -0.5% | 1,200,000 | 0.0% | 0.00% | – |
| Q3 2017 | $1,273,000 | +0.1% | 1,200,000 | 0.0% | 0.00% | – |
| Q2 2017 | $1,272,000 | +10.2% | 1,200,000 | 0.0% | 0.00% | – |
| Q1 2017 | $1,154,000 | -17.3% | 1,200,000 | -11.1% | 0.00% | – |
| Q4 2016 | $1,395,000 | +232.1% | 1,350,000 | +200.0% | 0.00% | – |
| Q3 2016 | $420,000 | +32.5% | 450,000 | 0.0% | 0.00% | – |
| Q2 2016 | $317,000 | -65.2% | 450,000 | -55.0% | 0.00% | – |
| Q1 2016 | $910,000 | -18.0% | 1,000,000 | 0.0% | 0.00% | – |
| Q4 2015 | $1,110,000 | – | 1,000,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|